Are you conducting cutting-edge research in psoriatic disease? 🔬 Don’t miss your chance to showcase your work at the 2025 GRAPPA Annual Meeting and Trainee Symposium, taking place in Bogotá, Colombia! The call for abstracts 2025 opens 1 week from today. 📆 Why Submit? ✅Selected abstract poster presenters will have their travel costs provided to present in Bogotá. Selected oral presenters and their mentors will have their travel costs provided to present in Bogotá. ✅Present your research to an international audience of leading experts. ✅Gain invaluable exposure and networking opportunities. Learn more and submit your abstract between January 10 through March 2. 🔗https://lnkd.in/ebRZbiFz
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA
Non-profit Organizations
Seattle, Washington 1,390 followers
Forum for networking & communication between international researchers in rheumatology & dermatology, industry, & PRPs.
About us
Originally inspired by the Assessment in Ankylosing Spondylitis Working Group (ASAS), GRAPPA was formed in 2003. GRAPPA has pulled together many different groups, including preeminent researchers and thought-leaders in psoriatic arthritis (PsA) and psoriasis (PsO). In 2015 a team of Patient Research Partners was added to round out our perspective. The idea was to form a consortium of rheumatologists, dermatologists, radiologists, epidemiologists, patient representatives and others who would like to contribute to the field of PsA. At the inaugural meeting in 2003, a consensus exercise started the group toward prioritizing domains of inquiry in PsA and PsO. Subsequent annual meetings have focused on identifying and initiating research projects, advancing standardized criteria for psoriatic arthritis registries, and developing treatment guidelines for PsA. GRAPPA is a 501(c)3 nonprofit organization with offices in Seattle, WA and members from around the world. Today, more than 1000 thought-leaders participate in GRAPPA including rheumatologists, dermatologists, radiologists, geneticists, methodologists, epidemiologists, patient research partners, and biopharmaceutical industry representatives. Approximately 75 percent of our members live and work outside North America; creating a truly international effort.
- Website
-
www.grappanetwork.org
External link for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA
- Industry
- Non-profit Organizations
- Company size
- 2-10 employees
- Headquarters
- Seattle, Washington
- Type
- Nonprofit
- Founded
- 2003
- Specialties
- Medical research and education
Locations
-
Primary
Get directions
3213 W. Wheeler St. #35
Seattle, Washington 98199, US
Employees at Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA
-
Janine K.
-
Kurt de Vlam
Pioneering Advances in Arthritis: Transforming Care through Research, Innovation, and Technology
-
Pamela Love
-
José Antonio Maldonado - Cocco
Profesor Asociado Consulto de Medicina - Universidad de Buenos Aires | Socio Gerente en Investigaciones Reumatológicas | Full Member of ASAS…
Updates
-
🎄 Season’s Greetings from GRAPPA! 🎄 As we wrap up 2024, we want to thank our amazing community for your dedication and support throughout the year. Wishing you a joyful holiday season filled with warmth, happiness, and time with loved ones. Here’s to a bright and successful 2025! Happy Holidays from all of us at GRAPPA! 💜💚✨
-
-
Congratulations to GRAPPA member Dr. Joel M Gelfand MD MSCE and the many others who contributed to this new publication in JAMA Dermatology on the results of the LITE Study! 📄 This important research represents a significant step forward in understanding and advancing care for psoriatic disease. 👏 🔗 Read the publication here: https://lnkd.in/gdpkyf5U #PsoriaticDisease #GRAPPAMembers #LITEStudy #JAMADerm #ResearchAdvances #psoriasis
James J. Leyden Professor of Dermatology & Epidemiology, Director Center for Clinical Sciences in Dermatology, Director Psoriasis & Phototherapy Treatment Center at University of Pennsylvania Perelman School of Medicine
The LITE study, a #pragmatic trial of home vs office #phototherapy for #psoriasis is out in the December issue of JAMA Dermatology and is honored by being selected as their Editor's Choice. You can access the article at: https://lnkd.in/e_RrREqs If you cannot access it, message me and I will send a pdf. LITE was funded by the Patient-Centered Outcomes Research Institute (PCORI) and conducted in partnership with the National Psoriasis Foundation. It was designed and executed with committees of patients, dermatology experts, and payers and was conducted at 42 dermatology practices across the US.
-
-
We’re thrilled to celebrate GRAPPA Founding Member Dr. Dafna Gladman on her appointment as an Officer to the Order of Canada! Dr. Gladman has made groundbreaking contributions to the field of psoriatic arthritis, advancing our understanding of this chronic disease through her pioneering research. Her unwavering advocacy has improved treatment availability and quality of care for patients worldwide. As a respected leader and mentor, Dr. Gladman continues to inspire the next generation of researchers, leaving a lasting legacy in the field. The Order of Canada recognizes individuals whose extraordinary contributions have enriched the lives of others and made a significant difference to the nation. Dr. Gladman’s achievements exemplify the Order’s motto: DESIDERANTES MELIOREM PATRIAM ("They desire a better country"). 👏 Join us in celebrating this incredible honour! Dafna Gladman https://smpl.is/9ynyj
-
-
🎙️New episode out wherever you listen to your podcasts: "Managing MSK Symptoms in PsO Patients: Who Should be in the Driver Seat?" A hot debate taken from the 2024 GRAPPA Annual Meeting, this episode of Inside GRAPPA is moderated by Dr. Mio Nakamura and features Dr. Laura Savage, Consultant Dermatologist from Leeds Teaching Hospital, UK, and Priv.-Doz. Dr. med. Fabian Proft, Rheumatologist from Berlin, Germany. Together, they tackle the vital question: Should dermatologists or rheumatologists be in the driver's seat when managing psoriatic arthritis (PsA)? 🎧 Also available here: https://smpl.is/9yeo4
-
A GRAPPA Workshop at IRACON was held last month in Bangalore, India. This dynamic and engaging event brought together clinicians and researchers to advance understanding and management of psoriatic disease. The workshop featured: ✅Didactic Lectures providing comprehensive overviews of psoriatic disease and its management. ✅Breakout Groups focused on hands-on assessment of psoriatic disease, allowing participants to apply practical skills in evaluating patients. ✅Case Discussions that highlighted real-world challenges and fostered interactive learning through expert-led dialogue. This well-received event served as an excellent platform for knowledge exchange and skill-building, furthering GRAPPA's mission to improve care for patients with psoriatic disease in the region. Thank you to Ashish Jacob Mathew for the organization and collaboration with the Indian Rheumatology Association and to all others who participated to make this event successful!
-
-
-
-
-
+2
-
-
📢 In Case You Missed It! The GRAPPA Virtual Congress Highlights from ACR 2024 is now available on-demand! 🎥 Catch up on key updates, expert insights, and the latest research advancements in psoriatic disease at your convenience. 🌟 Don’t miss this opportunity to stay informed and inspired. 🔗 https://smpl.is/9xkci Andre L. Ribeiro Sibel Z Aydin Siba Raychaudhuri Yusuf Can Edek Lourdes María Pérez Chada Priv.-Doz. Dr. med. Fabian Proft Maarten de Wit #PsoriaticDisease #GRAPPAHighlights #ACR2024
-
-
Giving Tuesday is today and we invite you to join us in supporting GRAPPA’s mission to advance research, education, and collaboration in psoriatic disease care. Your generosity helps us: 💠Drive innovation in psoriatic disease research. 💠Support educational initiatives for clinicians and researchers worldwide. 💠Foster a global network of collaboration to improve patient outcomes. Together, we can continue to make a meaningful difference in the lives of those impacted by psoriatic disease. 🤝Every contribution, big or small, moves us closer to breakthroughs that matter. Thank you for considering GRAPPA as part of your Giving Tuesday plans. Your support empowers progress and fuels hope. 🎁 Learn more about donating to GRAPPA Today. 🔗https://lnkd.in/gYePKXGG
-
-
The first GRAPPA Workshop in Sri Lanka recently took place and was a resounding success and marked an important milestone for the region. It was well-organized and provided valuable content, which included a unique opportunity to engage with patients during the breakout sessions on disease assessment. Congratulations to chathurika dandeniya, Ashish Jacob Mathew, and all others involved in making this first meeting a success!
-
-
-
-
-
+4
-
-
GRAPPA Members: We are excited to invite you to participate in COMPOSITION, a multicenter study aimed at advancing early psoriatic arthritis (PsA) diagnosis among psoriasis patients. By combining dermatologist-led screenings with patient questionnaires, COMPOSITION seeks to improve diagnostic accuracy and facilitate timely rheumatology referrals. Why Join COMPOSITION? This study offers a unique opportunity to enhance PsA screening, helping reduce diagnostic delays. Dermatology and rheumatology centers will collaborate to evaluate screening methods and contribute to the development of best practices in PsA diagnosis. How to Get Involved? To express interest, please complete the brief site selection questionnaire available here until December 15th, 2024: https://smpl.is/9x5a5 We look forward to your involvement in this initiative.
-